Royalty Pharma Plc (RPRX)
39.64
+0.55
(+1.41%)
USD |
NASDAQ |
Jan 21, 09:50
Royalty Pharma Price: 39.64 for Jan. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Denali Therapeutics, Inc. | 18.07 |
| Alnylam Pharmaceuticals, Inc. | 355.53 |
| Amgen, Inc. | 333.46 |
| PTC Therapeutics, Inc. | 73.89 |
| Zenas BioPharma, Inc. | 21.19 |
Price Related Metrics
| PE Ratio | 22.67 |
| PS Ratio | 9.652 |
| Price to Book Value | 2.640 |
| Price to Free Cash Flow | 21.64 |
| Earnings Yield | 4.41% |
| Market Cap | 16.94B |
| Operating PE Ratio | 14.81 |
| Normalized PE Ratio | 21.58 |